Navellier & Associates Inc Meridian Bioscience Inc Transaction History

Navellier & Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$18.01 - $28.32 $523,514 - $823,205	-29,068 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$19.76 - $29.89 $54,280 - $82,107	2,747 Added 10.44%	29,068 $763,000
Q4 2020 Feb 05, 2021	BUY	$15.73 - $21.66 $47,661 - $65,629	3,030 Added 13.01%	26,321 $492,000
Q3 2020 Nov 09, 2020	BUY	$13.54 - $26.41 $46,753 - $91,193	3,453 Added 17.41%	23,291 $395,000
Q2 2020 Aug 12, 2020	BUY	$7.84 - $23.29 $155,529 - $462,027	19,838 New	19,838 $462,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.